Clearpoint Neuro
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $9,215 | $8,485 | $7,771 | $8,122 |
Gross Profit | 5,556 | 5,132 | 4,762 | 4,847 |
EBITDA | -5,680 | -6,163 | -5,133 | -4,677 |
EBIT | -6,497 | -5,604 | -5,172 | |
Net Income | -5,837 | -6,026 | -5,386 | -4,974 |
Net Change In Cash | 9,215 | 8,485 | 7,771 | 8,122 |
Free Cash Flow | -2,643 | -6,355 | -1,506 | -1,211 |
Cash | 41,541 | 12,387 | 20,104 | 21,573 |
Basic Shares | 28,258 | 27,718 | 27,027 | 27,591 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $31,390 | $23,955 | $20,551 | $16,299 |
Gross Profit | 19,122 | 13,614 | 13,531 | 11,291 |
EBITDA | -17,843 | -20,989 | -15,577 | -12,745 |
EBIT | -19,746 | -22,446 | -16,354 | -13,437 |
Net Income | -18,914 | -22,089 | -16,435 | -14,410 |
Net Change In Cash | 31,390 | 23,955 | 20,551 | 16,299 |
Cost of Revenue | -26,494 | 34,010 | ||
Free Cash Flow | -9,225 | -14,771 | -17,313 | -12,865 |
Cash | 20,104 | 23,140 | 27,615 | 54,109 |
Basic Shares | 27,027 | 24,605 | 24,181 | 20,734 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.21 |
2025-03-31 | -$0.22 |
2024-12-31 | -$0.20 |
